Retrospective Claims Data and Patient Reported-Outcomes from COMMANDS Trial in Lower-Risk MDS

Amy DeZern, MD, MHS, discusses a retrospective study on healthcare claims for patients with MDS treated with luspatercept and reviews patient-reported outcomes from the COMMANDS trial.

Related Keywords

Amy Dezern , ,Evolving Treatment Landscape ,Myelodysplastic Syndromes ,Claims Data ,Patient Reported Outcomes ,Mds ,Mds Treatment ,Myelodysplastic Syndromes Treatment ,Mash 2023 ,Real World Outcomes ,Luspatercept ,Commands Trial ,Commands Study ,Healthcare Claims ,Healthcare Claims Database ,